- Previous Close
193.95 - Open
201.00 - Bid 190.10 x --
- Ask 193.20 x --
- Day's Range
192.10 - 201.00 - 52 Week Range
167.50 - 264.50 - Volume
6,364 - Avg. Volume
3,676 - Market Cap (intraday)
3.653B - Beta (5Y Monthly) 1.37
- PE Ratio (TTM)
9.34 - EPS (TTM)
20.58 - Earnings Date Jan 16, 2025 - Jan 20, 2025
- Forward Dividend & Yield 2.00 (1.04%)
- Ex-Dividend Date Aug 9, 2024
- 1y Target Est
--
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Mumbai, India.
nathbiogenes.com423
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: NATHBIOGEN.BO
View MorePerformance Overview: NATHBIOGEN.BO
Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NATHBIOGEN.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NATHBIOGEN.BO
View MoreValuation Measures
Market Cap
3.65B
Enterprise Value
2.99B
Trailing P/E
9.34
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.05
Price/Book (mrq)
0.57
Enterprise Value/Revenue
0.85
Enterprise Value/EBITDA
5.64
Financial Highlights
Profitability and Income Statement
Profit Margin
11.22%
Return on Assets (ttm)
3.45%
Return on Equity (ttm)
6.33%
Revenue (ttm)
3.51B
Net Income Avi to Common (ttm)
393.73M
Diluted EPS (ttm)
20.58
Balance Sheet and Cash Flow
Total Cash (mrq)
20.77M
Total Debt/Equity (mrq)
19.91%
Levered Free Cash Flow (ttm)
-262.71M